Related Experiment Videos
Management of postoperative constipation in anorectal surgery
Diseases of the Colon and Rectum
|April 1, 1979
Summary
Senokot S, a combination of senna and docusate, effectively prevents and treats postoperative constipation in patients undergoing proctologic surgery. This treatment achieved excellent or good results in 94% of patients with minimal side effects.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Postoperative constipation is a common complication following proctologic surgery.
- Effective management is crucial for patient recovery and comfort.
Purpose of the Study:
- To evaluate the efficacy and safety of Senokot S in managing postoperative constipation.
- To assess the impact of Senokot S on bowel movement frequency and stool consistency.
Main Methods:
- A study involving 50 patients undergoing proctologic operations.
- Administration of standardized senna concentrate and dioctyl sodium sulfosuccinate (Senokot S).
- Dosage adjusted based on patient response, up to a maximum of four tablets twice daily.
Main Results:
- All patients achieved bowel movements without the need for enemas.
- 94% of patients experienced excellent or good treatment outcomes.
- 88% of patients had satisfactory fecal consistency on discharge; 12% had loose stools.
- 92% experienced bowel movements after the first or second dose.
- No significant side effects were reported, except for one case of diarrhea in a patient with a history of loose stools.
Conclusions:
- Senokot S is a valuable and safe option for the postoperative management of constipation in proctologic surgery patients.
- The treatment demonstrates high efficacy and a favorable safety profile, regardless of patient age.